Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 24 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-1.84 Insider Own7.52% Shs Outstand90.08M Perf Week0.40%
Market Cap112.60M Forward P/E- EPS next Y-0.88 Insider Trans0.00% Shs Float83.31M Perf Month-0.79%
Income-97.92M PEG- EPS next Q-0.23 Inst Own62.03% Short Float3.39% Perf Quarter-2.34%
Sales0.00M P/S- EPS this Y52.89% Inst Trans-2.57% Short Ratio7.25 Perf Half Y19.05%
Book/sh0.93 P/B1.35 EPS next Y11.72% ROA-91.94% Short Interest2.82M Perf Year-28.16%
Cash/sh1.08 P/C1.16 EPS next 5Y15.50% ROE-112.05% 52W Range0.95 - 3.11 Perf YTD-16.67%
Dividend Est.- P/FCF- EPS past 5Y31.12% ROI-116.56% 52W High-59.81% Beta1.83
Dividend TTM- Quick Ratio5.09 Sales past 5Y0.00% Gross Margin- 52W Low32.26% ATR (14)0.08
Dividend Ex-Date- Current Ratio5.09 EPS Y/Y TTM49.30% Oper. Margin0.00% RSI (14)46.61 Volatility5.34% 5.96%
Employees77 Debt/Eq0.01 Sales Y/Y TTM- Profit Margin- Recom1.40 Target Price11.50
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q47.48% Payout- Rel Volume0.30 Prev Close1.24
Sales Surprise- EPS Surprise-15.38% Sales Q/Q- EarningsMay 08 BMO Avg Volume389.25K Price1.25
SMA20-2.36% SMA50-2.99% SMA200-5.66% Trades Volume115,027 Change0.81%
Date Action Analyst Rating Change Price Target Change
Oct-21-22Downgrade SVB Leerink Outperform → Mkt Perform $5
Sep-19-22Resumed H.C. Wainwright Buy $26
Apr-15-21Initiated Aegis Capital Buy $55
Mar-24-21Initiated JMP Securities Mkt Outperform $55
Oct-02-20Initiated SVB Leerink Outperform $45
Aug-26-20Initiated Piper Sandler Overweight $71
Aug-07-20Resumed ROTH Capital Buy $64
Jul-20-20Initiated BMO Capital Markets Outperform $40
Jun-05-20Initiated Wedbush Outperform $59
May-11-20Initiated H.C. Wainwright Buy $45
May-23-24 06:00AM
May-20-24 10:00AM
May-17-24 02:35PM
May-16-24 05:54PM
May-09-24 10:23AM
06:58AM Loading…
May-08-24 06:36AM
May-06-24 06:30AM
May-01-24 10:02AM
Apr-30-24 06:30AM
Apr-29-24 11:11AM
Apr-04-24 06:30AM
Mar-21-24 12:14PM
11:37AM Loading…
Mar-20-24 06:30AM
Mar-08-24 06:53AM
Mar-07-24 06:30AM
Feb-29-24 06:30AM
Feb-23-24 09:02PM
Feb-22-24 10:59AM
Feb-15-24 06:30AM
Feb-01-24 06:30AM
Jan-05-24 06:35AM
Nov-21-23 06:30AM
Nov-14-23 01:25PM
06:36AM Loading…
Nov-07-23 06:30AM
Nov-02-23 06:30AM
Oct-26-23 06:30AM
Oct-24-23 07:51AM
Oct-16-23 06:30AM
Oct-15-23 06:30AM
Oct-11-23 06:30AM
Oct-10-23 09:07AM
Oct-09-23 04:01PM
Oct-04-23 06:30AM
Sep-06-23 06:30AM
Aug-21-23 08:00AM
Aug-17-23 06:30AM
Aug-07-23 09:50AM
Aug-03-23 06:47AM
Aug-01-23 06:30AM
Jul-28-23 04:19PM
Jul-27-23 06:30AM
Jul-25-23 08:00AM
Jul-24-23 10:33AM
Jun-29-23 06:30AM
Jun-27-23 09:56AM
Jun-26-23 03:44PM
May-31-23 07:42AM
May-30-23 06:30AM
May-17-23 10:00AM
May-16-23 01:07PM
May-11-23 06:40AM
May-09-23 06:30AM
May-06-23 06:30AM
May-04-23 06:30AM
Apr-27-23 06:30AM
Apr-26-23 06:30AM
Apr-13-23 08:00AM
Apr-06-23 02:10PM
Apr-05-23 12:30PM
Mar-02-23 06:30AM
Feb-28-23 05:22AM
Feb-26-23 08:23AM
Feb-23-23 06:30AM
Feb-22-23 06:30AM
Feb-16-23 06:30AM
Feb-09-23 06:30AM
Jan-25-23 06:30AM
Jan-18-23 06:31AM
Nov-17-22 08:04AM
Nov-10-22 06:30AM
Nov-03-22 06:30AM
Oct-27-22 06:30AM
Oct-21-22 03:14PM
Oct-20-22 04:01PM
Oct-10-22 07:00AM
Oct-04-22 06:30AM
Sep-20-22 01:39PM
Sep-19-22 03:03PM
Sep-16-22 10:11AM
Sep-01-22 06:30AM
Aug-16-22 06:30AM
Aug-04-22 06:30AM
Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The firm's products include IMU-838, IMU-935, and IMU-856. The company is headquartered in New York, NY.